Epilepsy and cannabinoids
3 matching public articles
Candidate association · not a treatment claimLoading compound profile…
Synthetic cannabinoids
A fatty amide obtained by the formal condensation of arachidonic acid with 2-chloroethanamine. It is a potent agonist of the CB<small><sub>1</sub></small> receptor (Ki = 1.4 nM) and also has a low affinity for the CB<small><sub>2</sub></small> receptor (Ki = 3100 nM).
Definition: CHEBI:191854 · Chemical Entities of Biological Interest · release 253
Identity & provenance
C22H36ClNO · molecular weight 365.989
Sources: ChEBI · 253PubChem computed properties · pug-55ed32a9105ce428
0 referenced plant-occurrence records. They are identity candidates, not clinical evidence.
Research areas
Document links and organism occurrence are candidates, not proof of efficacy, safety or a treatment recommendation.
3 matching public articles
Candidate association · not a treatment claim2 matching public articles
Candidate association · not a treatment claim1 matching public articles
Candidate association · not a treatment claim1 matching public articles
Candidate association · not a treatment claim1 matching public articles
Candidate association · not a treatment claim1 matching public articles
Candidate association · not a treatment claim1 matching public articles
Candidate association · not a treatment claim1 matching public articles
Candidate association · not a treatment claimLinked local records
Links use source-reported active ingredients or study intervention names and remain candidates, not treatment claims.
0 exact source-intervention matches.
No registered study intervention matched.
Latest documents